Disposition of [14C]-LY2886721 Following Oral Administration in Healthy Human Subjects.
Phase of Trial: Phase I
Latest Information Update: 10 Aug 2011
At a glance
- Drugs LY 2886721 (Primary)
- Indications Alzheimer's disease
- Focus Pharmacokinetics
- 10 Aug 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 09 Jun 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 09 Jun 2011 New trial record